Enable job alerts via email!
A leading educational institution in the UK is seeking a dedicated data scientist to develop AI approaches for drug safety science utilizing real-world clinical data. You will employ neural language models to classify veterinary clinical records and identify adverse events. A doctoral or master's degree in relevant fields is required, with experience in pharmacovigilance being desirable but not essential. This position is available for up to 15 months with a start date of 1 October 2025.
We are looking for a dedicated and ambitious data scientist to continue our work in developing AI / informatics approaches to efficiently utilise real world clinical data for drug safety science (pharmacovigilance). Our previous work has shown that SAVSNET veterinary free-text clinical narratives are a source of real-world pharmacovigilance data. Here we will extend this work by using neural language models such as bidirectional encoder representations using transformers (BERT) models (including our own PetBERT model) to classify large volumes of records in order to determine if clusters of adverse events can be identified and then used in pharmaco-epidemiological studies.
Separately, we will pilot an assessment of whether association between relevant charged items and recorded events that may indicate an adverse event (for example, a change in prescription from Lokivetmab (Cytopoint) to Oclacitinib (Apoquel) or vice versa signifying a possible lack of efficacy adverse event).
Commitment to Diversity
The University of Liverpool is committed to enhancing workforce diversity. We actively seek to attract, develop, and retain colleagues with diverse backgrounds and perspectives. We welcome applications from all genders/gender identities, Black, Asian, or Minority Ethnic backgrounds, individuals living with a disability, and members of the LGBTQIA+ community.